Willis Towers Watson Public Company Earnings Calls
| Release date | Apr 30, 2026 |
| EPS estimate | $3.65 |
| EPS actual | $3.72 |
| EPS Surprise | 1.92% |
| Revenue estimate | 2.413B |
| Revenue actual | 2.412B |
| Revenue Surprise | -0.0613% |
| Release date | Feb 03, 2026 |
| EPS estimate | $7.96 |
| EPS actual | $8.12 |
| EPS Surprise | 2.01% |
| Revenue estimate | 2.853B |
| Revenue actual | 2.936B |
| Revenue Surprise | 2.91% |
| Release date | Oct 30, 2025 |
| EPS estimate | $3.05 |
| EPS actual | $3.07 |
| EPS Surprise | 0.656% |
| Revenue estimate | 2.275B |
| Revenue actual | 2.288B |
| Revenue Surprise | 0.585% |
| Release date | Jul 31, 2025 |
| EPS estimate | $2.63 |
| EPS actual | $2.86 |
| EPS Surprise | 8.75% |
| Revenue estimate | 2.229B |
| Revenue actual | 2.261B |
| Revenue Surprise | 1.45% |
Last 4 Quarters for Willis Towers Watson Public Company
Below you can see how WTW performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 31, 2025 |
| Price on release | $315.81 |
| EPS estimate | $2.63 |
| EPS actual | $2.86 |
| EPS surprise | 8.75% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $313.11 |
| Jul 28, 2025 | $309.35 |
| Jul 29, 2025 | $302.30 |
| Jul 30, 2025 | $301.83 |
| Jul 31, 2025 | $315.81 |
| Aug 01, 2025 | $314.77 |
| Aug 04, 2025 | $320.67 |
| Aug 05, 2025 | $324.50 |
| Aug 06, 2025 | $325.54 |
| 4 days before | 0.86% |
| 4 days after | 3.08% |
| On release day | -0.329% |
| Change in period | 3.97% |
| Release date | Oct 30, 2025 |
| Price on release | $317.00 |
| EPS estimate | $3.05 |
| EPS actual | $3.07 |
| EPS surprise | 0.656% |
| Date | Price |
|---|---|
| Oct 24, 2025 | $328.34 |
| Oct 27, 2025 | $326.86 |
| Oct 28, 2025 | $320.37 |
| Oct 29, 2025 | $317.54 |
| Oct 30, 2025 | $317.00 |
| Oct 31, 2025 | $313.10 |
| Nov 03, 2025 | $314.00 |
| Nov 04, 2025 | $322.81 |
| Nov 05, 2025 | $323.06 |
| 4 days before | -3.45% |
| 4 days after | 1.91% |
| On release day | -1.23% |
| Change in period | -1.61% |
| Release date | Feb 03, 2026 |
| Price on release | $335.10 |
| EPS estimate | $7.96 |
| EPS actual | $8.12 |
| EPS surprise | 2.01% |
| Date | Price |
|---|---|
| Jan 28, 2026 | $314.33 |
| Jan 29, 2026 | $316.25 |
| Jan 30, 2026 | $317.47 |
| Feb 02, 2026 | $316.61 |
| Feb 03, 2026 | $335.10 |
| Feb 04, 2026 | $339.74 |
| Feb 05, 2026 | $327.32 |
| Feb 06, 2026 | $330.04 |
| Feb 09, 2026 | $290.09 |
| 4 days before | 6.61% |
| 4 days after | -13.43% |
| On release day | 1.38% |
| Change in period | -7.71% |
| Release date | Apr 30, 2026 |
| Price on release | $256.20 |
| EPS estimate | $3.65 |
| EPS actual | $3.72 |
| EPS surprise | 1.92% |
| Date | Price |
|---|---|
| Apr 24, 2026 | $287.73 |
| Apr 27, 2026 | $289.34 |
| Apr 28, 2026 | $290.88 |
| Apr 29, 2026 | $290.11 |
| Apr 30, 2026 | $256.20 |
| May 01, 2026 | $256.34 |
| May 04, 2026 | $260.02 |
| May 05, 2026 | $259.47 |
| May 06, 2026 | $252.41 |
| 4 days before | -10.96% |
| 4 days after | -1.48% |
| On release day | 0.0546% |
| Change in period | -12.28% |
Willis Towers Watson Public Company Earnings Call Transcript Summary of Q1 2026
WTW reported Q1 2026 results with 3% organic revenue growth, an adjusted operating margin of 22.3% (up ~70 bps year-over-year) and adjusted diluted EPS of $3.72 (up 19% vs. Q1 2025). Revenue was at the low end of plan, driven by a challenging and volatile market backdrop (notably geopolitical disruption in the Middle East) that caused delays in some advisory work and a miss vs. new-business expectations in Risk & Broking (R&B). Management reiterated confidence in the long-term strategy: continued investment in AI, proprietary data, specialization and global scale. They highlighted early commercial traction from AI-enabled products (Rewards AI, WorkVue, Coverage Gap Analysis, Navigator, Neuron operating system, CRB digital claims platform) and the integration of Newfront technology and talent to accelerate productivity and revenue generation. Segment highlights: Health, Wealth & Career (HWC) grew 3% with Health up 6% and continued robust demand driven by high healthcare inflation; Career was pressured (-3%) by regional project delays but management expects improvement later in the year; R&B grew 2% (1% excluding certain items), with a softer Q1 due to strong prior-year comps, timing of new business and some pricing pressure—management narrowed R&B full-year guidance to mid-single-digit organic growth. ICT grew 5% led by technology sales (Radar). Financial/operational details: foreign exchange provided a ~$0.25 EPS tailwind in Q1 and is expected to be ~$0.35 for the full year; GAAP and adjusted tax rates trended lower vs. prior year; free cash flow was negative $65M (improved vs prior year) and the company returned $388M to shareholders in the quarter (including $300M buybacks). Capital allocation priorities remain: share repurchases (at least $1B planned), dividends and disciplined M&A. Management reaffirmed medium-term objectives of mid-single-digit organic growth, continued margin expansion (targeting ~100 bps average annual adjusted operating margin expansion over the next two years) and free cash flow margin improvement.
Sign In
Buy WTW